U.S. RESEARCH ROUNDUP-Okta, Salesforce, Sarepta Therapeutics

Dine Brands Global

29/02/2024 07:06

Feb 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies, including Okta, Salesforce and Sarepta Therapeutics, on Thursday. 
    
    HIGHLIGHTS
                 * Clearwater Analytics Holdings Inc  CWAN.N : JP Morgan cuts to neutral from
 overweight
 
                 * Okta Inc  OKTA.O : Piper Sandler raises target price to $110 from $85    
 
                 * Salesforce Inc  CRM.N : Barclays raises target price to $355 from $325    
 
                 * Sarepta Therapeutics Inc  SRPT.O : Leerink Partners raises target price to $165
 from $145    
 
                 * Universal Health Services Inc  UHS.N : Leerink Partners raises target to $192 from
 $174    
 
        
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in
alphabetical order. 
    
                 * Acadia Healthcare Company Inc  ACHC.O : Leerink Partners raises target to $100 from $95
 
                 * Advance Auto Parts Inc  AAP.N : JP Morgan raises target price to $68 from $55
 
                 * Alkami Technology Inc  ALKT.O : JP Morgan raises target price to $31 from $27
 
                 * Array Technologies Inc  ARRY.O : Scotiabank cuts target price to $25 from $33
 
                 * Atea Pharmaceuticals Inc  AVIR.O : Leerink Partners raises target price to $5 from $4
 
                 * Avidxchange Holdings Inc  AVDX.O : Piper Sandler raises target price to $14 from $13
 
                 * Avidxchange Holdings Inc  AVDX.O : Susquehanna raises target price to $16 from $15
 
                 * Clearwater Analytics Holdings Inc  CWAN.N : JP Morgan cuts target price to $22 from $24
 
                 * Clearwater Analytics Holdings Inc  CWAN.N : JP Morgan cuts to neutral from overweight
 
                 * Crowdstrike Holdings Inc  CRWD.O : JP Morgan raises target price to $350 from $300
 
                 * Dine Brands Global Inc  DIN.N : Wedbush raises target price to $48 from $46
 
                 * Editas Medicine Inc  EDIT.O : Leerink Partners raises target price to $10 from $9
 
                 * Gulfport Energy Corp  GPOR.N : Truist Securities raises target price to $184 from $170
 
                 * Inari Medical Inc  NARI.O : BTIG cuts target price to $86 from $93
 
                 * Inari Medical Inc  NARI.O : Truist Securities cuts target price to $61 from $63
 
                 * Marvell Technology Inc  MRVL.O : Oppenheimer raises target price to $80 from $70
 
                 * Mersana Therapeutics Inc  MRSN.O : Truist Securities raises to buy from hold
 
                 * Monster Beverage Corp  MNST.O : Jefferies raises target price to $69 from $66
 
                 * Nutanix Inc  NTNX.O : JP Morgan raises target price to $70 from $65
 
                 * Nutanix Inc  NTNX.O : Piper Sandler raises target price to $76 from $67
 
                 * Okta Inc  OKTA.O : BTIG raises target price to $124 from $100
 
                 * Okta Inc  OKTA.O : Piper Sandler raises target price to $110 from $85
 
                 * Permian Resources Corp  PR.N : Susquehanna raises target price to $16 from $15
 
                 * Revance Therapeutics Inc  RVNC.O : Piper Sandler cuts target price to $20 from $42
 
                 * Rxsight Inc  RXST.O : JP Morgan raises target price to $62 from $40
 
                 * Salesforce Inc  CRM.N : Barclays raises target price to $355 from $325
 
                 * Salesforce Inc  CRM.N : Raymond James raises target price to $380 from $300
 
                 * Sarepta Therapeutics Inc  SRPT.O : Leerink Partners raises target price to $165 from $145
 
                 * Schrodinger Inc  SDGR.O : Piper Sandler cuts target price to $50 from $60
 
                 * Shoals Technologies Group Inc  SHLS.O : Piper Sandler cuts target price to $16 from $20
 
                 * Silk Road Medical Inc  SILK.O : JP Morgan raises target price to $19 from $10
 
                 * Slr Investment Corp  SLRC.O : JP Morgan cuts target price to $15 from $15.5
 
                 * Snowflake Inc.  SNOW.N : D.A. Davidson cuts target price to $230 from $260
 
                 * Snowflake Inc.  SNOW.N : Melius Research cuts target price to $185 from $202
 
                 * Snowflake Inc.  SNOW.N : Scotiabank cuts target price to $207 from $226
 
                 * Steven Madden Ltd  SHOO.O : Wedbush raises target price to $41 from $38
 
                 * United Parks & Resorts Inc  PRKS.N : JP Morgan raises target price to $61 from $57
 
                 * Universal Health Services Inc  UHS.N : Leerink Partners raises target to $192 from $174
 
                 * Vacasa Inc  VCSA.O : JP Morgan raises target price to $10 from $8
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))